Melanocytic nevus epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Line 16: | Line 16: | ||
===Congenital melanocytic nevi (CMN)=== | ===Congenital melanocytic nevi (CMN)=== | ||
*The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.<ref name="pmid17377384">{{cite journal |vauthors=Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L |title=Congenital melanocytic nevus: an epidemiologic study in Italy |journal=Dermatology (Basel) |volume=214 |issue=3 |pages=227–30 |date=2007 |pmid=17377384 |doi=10.1159/000099587 |url=}}</ref> | *The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.<ref name="pmid17377384">{{cite journal |vauthors=Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L |title=Congenital melanocytic nevus: an epidemiologic study in Italy |journal=Dermatology (Basel) |volume=214 |issue=3 |pages=227–30 |date=2007 |pmid=17377384 |doi=10.1159/000099587 |url=}}</ref> | ||
===Melanoma=== | |||
*22 in 100,000 people is the age-standardized annual incidence of melanoma worldwide and it has risen more than 10-fold in past ten years.<ref name="pmid8053717">{{cite journal |vauthors=Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ |title=Melanoma risk in individuals with clinically atypical nevi |journal=Arch Dermatol |volume=130 |issue=8 |pages=999–1001 |date=August 1994 |pmid=8053717 |doi= |url=}}</ref><ref name="pmid29313949">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2018 |journal=CA Cancer J Clin |volume=68 |issue=1 |pages=7–30 |date=January 2018 |pmid=29313949 |doi=10.3322/caac.21442 |url=}}</ref> | |||
==References== | ==References== |
Revision as of 14:10, 21 May 2019
Melanocytic nevus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Melanocytic nevus epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Melanocytic nevus epidemiology and demographics |
Risk calculators and risk factors for Melanocytic nevus epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]
Overview
Darker skin shades tend to have fewer moles compared to fair complexion.
Epidemiology and demographics
Acquired melanocytic nevi
- The number of acquired moles among white children depends on the geographical area and sun exposure and its intensity.[1]
- According to the American Academy of Dermatology, the majority of moles appear during the first two decades of a person’s life. [2]
- Darker skin shades tend to have fewer moles.
Congenital melanocytic nevi (CMN)
- The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.[3]
Melanoma
- 22 in 100,000 people is the age-standardized annual incidence of melanoma worldwide and it has risen more than 10-fold in past ten years.[4][5]
References
- ↑ Valiukeviciene S, Miseviciene I, Gollnick H (May 2005). "The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania". Arch Dermatol. 141 (5): 579–86. doi:10.1001/archderm.141.5.579. PMID 15897379.
- ↑ Gallagher RP, McLean DI (July 1995). "The epidemiology of acquired melanocytic nevi. A brief review". Dermatol Clin. 13 (3): 595–603. PMID 7554507.
- ↑ Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L (2007). "Congenital melanocytic nevus: an epidemiologic study in Italy". Dermatology (Basel). 214 (3): 227–30. doi:10.1159/000099587. PMID 17377384.
- ↑ Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ (August 1994). "Melanoma risk in individuals with clinically atypical nevi". Arch Dermatol. 130 (8): 999–1001. PMID 8053717.
- ↑ Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.